Pulse Biosciences CFO Jon Skinner files initial beneficial ownership statement
PLSE•Form 3 filing
- Pulse Biosciences CFO Jon Skinner filed an initial Form 3 on Feb. 3, 2025.
Related News
Bone Biologics announces annual shareholder meeting
BBLG•
Nasdaq trade halt continues <UCFIW.O> reason not available at 08:03 pm
UCFIW•
Rubrik files Form 3 as director Rakefet Russak-Aminoach reports no holdings
RBRK•
Nasdaq trade halt continues MCTA.O reason not available at 08:03 PM
MCTA•
Consumer Portfolio Services CEO Charles E. Bradley Jr disposes of 125,000 common shares for $1.18 million
CPSS•